Search
10X Genomics Inc
TXGAdd to Watchlist
70.000USD
-11.550-14.16%
Market hours 10/30, 12:15（ET）
9.12BMarket Cap
LossP/E TTM
Today
-14.16%
5 Days
+0.36%
1 Month
-22.26%
6 Months
+246.53%
Year to Date
+329.18%
1 Year
+442.64%
Key Figures
76.385Open
84.400High
219.47KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.17%Turnover Ratio
81.550Prev. Close
68.695Low
15.74MTurnover
LossP/E Static
11.05P/B
0.00%Div Yield TTM
-2.36%ROA
102.81052wk High
0.17Volume Ratio
-182.63MNet Profit
130.29MShares
-0.1738EPS TTM
2.11Beta
-2.98%ROE
12.34052wk Low
19.26%Amplitude
72.76%Gross Margin
9.12BMarket Cap
7.29Reward/Risk
4.71%Risk Rate
Recent
Earnings
10X Genomics Inc Stock (TXG) Moved Up by 7.42% on Sep 24: What Signal Does It Send?
• 10x Genomics stock rose due to strong momentum and positive technical indicators. • Strong Atera platform demand and AI integrations drove fundamental investor optimism. • Annual revenue reached $642.82M alongside a net profit of -$43.54M.
TradingKeyThu, Sep 24
Today’s Market Recap: Markets Rally as Oil Retreats Amid Tech Breakthroughs and Geopolitical Tensions
US Indices Gain as Oil Supply Fears Ease; Trump Admin Presses Fed Subpoena Case
TradingKeyTue, Mar 17
10X Genomics Inc's Score
-0.07vs previous score
Forecast7.33
Financial Health7.27
Technical5.51
Valuation Dimensions8.67
Institutional Confidence10.00
Risk Assessment4.54
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
10X Genomics Inc Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
2026-11-05
Reporting Period
2026Q2
Earnings / Forecast
-0.14/-0.24
Revenue / Forecast
151.04M/146.79M
10X Genomics Inc Profile
SectorHealthcare Equipment & Supplies
Ticker SymbolTXG
Number of employees1306
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| ARK Investment Management LLC | 10.03% |
| Fidelity Management & Research Company LLC | 8.34% |
| BlackRock Institutional Trust Company, N.A. | 7.09% |
| Vanguard Portfolio Management, LLC | 5.91% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 55.99% |
| Investment Advisor/Hedge Fund | 26.35% |
| Hedge Fund | 12.98% |
| Bank and Trust | 4.83% |
Related Instruments
-0.94%
-1.84%
+1.54%
-2.09%
-2.16%
+0.04%
+0.21%
-5.08%
+0.21%
-1.09%
+0.02%
+0.96%
+0.01%
-4.84%
+0.15%
-1.21%
+0.62%
-1.46%
-3.92%
-3.94%Popular Instruments
51956.700
-380.700 (-0.73%)
28427.900
-637.100 (-2.19%)
7593.200
-82.500 (-1.07%)
12783.000
-58.000 (-0.45%)
62377.000
-1607.000 (-2.51%)
6123.300
-75.300 (-1.22%)
103.808
+1.406 (+1.37%)
346.890
-2.020 (-0.58%)
204.740
-8.920 (-4.17%)
3895.040
-125.910 (-3.13%)
FAQs
What is the current price of 10X Genomics Inc (TXG)?
The current price of 10X Genomics Inc (TXG) is 81.55.
What is the symbol of 10X Genomics Inc?
The ticker symbol of 10X Genomics Inc is TXG.
What is the 52-week high of 10X Genomics Inc?
The 52-week high of 10X Genomics Inc is 102.81.
What is the 52-week low of 10X Genomics Inc?
The 52-week low of 10X Genomics Inc is 12.34.
What is the market capitalization of 10X Genomics Inc?
The market capitalization of 10X Genomics Inc is 10.63B.
Is 10X Genomics Inc (TXG) currently rated as Buy, Hold, or Sell?
According to analysts, 10X Genomics Inc (TXG) has an overall rating of Buy, with a price target of 73.93.
What is the Earnings Per Share (EPS TTM) of 10X Genomics Inc (TXG)?
The Earnings Per Share (EPS TTM) of 10X Genomics Inc (TXG) is -0.17.